FDA Approves Once-Daily Parkinson’s Pill Juvmo: What Patients Need To Know

The FDA has approved AbbVie’s once-daily Parkinson’s pill Juvmo, but what does the new treatment mean for patients? Here’s how it works, its benefits and side effects.